Matches in Wikidata for { <http://www.wikidata.org/entity/Q63320298> ?p ?o ?g. }
Showing items 1 to 34 of
34
with 100 items per page.
- Q63320298 description "clinical trial" @default.
- Q63320298 description "ensayu clínicu" @default.
- Q63320298 description "klinisch onderzoek" @default.
- Q63320298 description "клінічне випробування" @default.
- Q63320298 name "Observational Study of Biphasic Insulin Aspart 30 Alone or in Combination With Oral Hypoglycaemic Agents in Subjects With Type 2 Diabetes" @default.
- Q63320298 type Item @default.
- Q63320298 label "Observational Study of Biphasic Insulin Aspart 30 Alone or in Combination With Oral Hypoglycaemic Agents in Subjects With Type 2 Diabetes" @default.
- Q63320298 prefLabel "Observational Study of Biphasic Insulin Aspart 30 Alone or in Combination With Oral Hypoglycaemic Agents in Subjects With Type 2 Diabetes" @default.
- Q63320298 P1050 Q63320298-917FB95E-8ECB-4714-85A4-AA53D60C5534 @default.
- Q63320298 P1132 Q63320298-B6E9BD86-3EAC-4DF0-9D80-C6E4DD8712D3 @default.
- Q63320298 P1476 Q63320298-7072724B-0A51-468E-8A19-941BA32BCBE3 @default.
- Q63320298 P1813 Q63320298-81682228-CFD6-4F60-A4B5-FBE4A0773E6A @default.
- Q63320298 P3098 Q63320298-2E9288B3-D715-438A-8E7F-3B504300E7A8 @default.
- Q63320298 P31 Q63320298-B628D2DA-74A9-4361-8632-8D8862338A72 @default.
- Q63320298 P4844 Q63320298-1F01EA7B-782F-4499-A073-ADE873695392 @default.
- Q63320298 P4844 Q63320298-60EE8E5C-1123-45EB-BC47-F1B2DAD31A61 @default.
- Q63320298 P4844 Q63320298-C15895F9-B5A6-4EEC-A53C-D7F42E32A67C @default.
- Q63320298 P580 Q63320298-0E75B119-E241-4A88-8FA0-DB7287FEE637 @default.
- Q63320298 P582 Q63320298-4524C67B-C20D-4CD7-B722-D341928BE360 @default.
- Q63320298 P6153 Q63320298-0CF98C0D-25F1-4461-84C9-F98E62608ABD @default.
- Q63320298 P8363 Q63320298-9FA177F8-06A4-4AF9-853E-5D9D44802D1B @default.
- Q63320298 P1050 Q12206 @default.
- Q63320298 P1132 "+33010" @default.
- Q63320298 P1476 "A Multi-center, Prospective, Non-interventional Evaluation of Efficacy, Safety and Convenience of Using NovoMix 30 as Monotherapy, or in Combination With OHAs, in the Treatment of Type 2 Diabetic Patients in Routine Clinical Practice" @default.
- Q63320298 P1813 "PRESENT" @default.
- Q63320298 P3098 "NCT01536600" @default.
- Q63320298 P31 Q30612 @default.
- Q63320298 P4844 Q1929845 @default.
- Q63320298 P4844 Q2754775 @default.
- Q63320298 P4844 Q58125727 @default.
- Q63320298 P580 "2004-09-01T00:00:00Z" @default.
- Q63320298 P582 "2006-12-01T00:00:00Z" @default.
- Q63320298 P6153 Q818846 @default.
- Q63320298 P8363 Q818574 @default.